Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology


Reorganizations
Baxter Updates Website
Baxter BioPharma Solutions (Round Lake, IL) organized its website to help users quickly find solutions for scientific and formulation challenges, increase molecules' market presence, and optimize manufacturing efficiency and supply. The site's content now includes manufacturing videos and animation featuring the "PROMAXX" microsphere technology.

Noveon Changes Name
Noveon (Cleveland, OH), a subsidiary of the Lubrizol Corporation (Wickliffe, OH), changed its name to Lubrizol Advanced Materials on June 4, 2007 in North America. Subsidiaries of Lubrizol in Europe and Asia were scheduled to change their names in early July. The name change is part of the Lubrizol Corporation's plan to create a common identity for itself and its subsidiaries. The corporation is a specialty-chemicals company with a technology portfolio.

Agreement
ABB Boosts GE's Separation-Media Production
ABB (Zurich, Switzerland) agreed to supply GE Healthcare (Chalfont St. Giles, UK) with a "System 800xA" extended automation solution to boost GE's production of protein separation media for biopharmaceuticals by 50% at its Uppsala, Sweden facility.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here